Inex Medicaments Profile
Key Indicators
- Authorised Capital ₹ 0.50 M
- Paid Up Capital ₹ 0.50 M
- Company Age 15 Year, 4 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 1.50 Cr
- Revenue Growth 4.75%
- Profit Growth 3.08%
- Ebitda -25.03%
- Net Worth 15.14%
- Total Assets 0.42%
About Inex Medicaments
Inex Medicaments Private Limited (IMPL) is a leading Private Limited Indian Non-Government Company incorporated in India on 06 November 2009 and has a history of 15 years and four months. Its registered office is in Kanchipuram, Tamil Nadu, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.50 M and a paid-up capital of Rs 0.50 M.
The company currently has active open charges totaling ₹1.50 Cr.
Ajithkumar and Gopalakrishnan Srinivasan serve as directors at the Company.
Company Details
- Location
Kanchipuram, Tamil Nadu, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
- Social Media
Corporate Identity Details
- CIN/LLPIN
U51909TN2009PTC073452
- Company No.
073452
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
06 Nov 2009
- Date of AGM
29 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Chennai
Industry
Pharma
What products or services does Inex Medicaments Private Limited offer?
Inex Medicaments Private Limited offers a wide range of products and services, including Skin Care, Bath Essentials, Facewash, Health Conditions, Heart Care.
Who are the key members and board of directors at Inex Medicaments?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Gopalakrishnan Srinivasan  | Managing Director | 06-Nov-2009 | Current |
Board Members (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Ajithkumar | Director | 06-Nov-2009 | Current |
Financial Performance of Inex Medicaments.
Inex Medicaments Private Limited, for the financial year ended 2023, experienced modest growth in revenue, with a 4.75% increase. The company also saw a slight improvement in profitability, with a 3.08% increase in profit. The company's net worth Soared by an impressive increase of 15.14%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Inex Medicaments?
In 2023, Inex Medicaments had a promoter holding of 85.00% and a public holding of 15.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
Open Charges
₹15.00 M
Satisfied Charges
₹0
Charges Breakdown by Lending Institutions
- City Union Bank Limited : 1.50 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 13 May 2016 | City Union Bank Limited | ₹1.50 Cr | Open |
How Many Employees Work at Inex Medicaments?
Unlock and access historical data on people associated with Inex Medicaments, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Inex Medicaments, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Inex Medicaments's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Latest Updates, News, and FAQs on Inex Medicaments
Recent activity within the organization
- Annual General Meeting
Inex Medicaments Private Limited last Annual general meeting of members was held on 29 Sep 2024 as per latest MCA records.
- Balance Sheet
Inex Medicaments Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Chennai.
- Charges
A charge with City Union Bank Limited of Rs. 15.00 M registered on 13 May 2016 with Charge ID 100038012 was modified on 27 Mar 2019.
- Charges
A charge with City Union Bank Limited amounted to Rs. 15.00 M with Charge ID 100038012 was registered on 13 May 2016.
- Director Appointment
Ajithkumar was appointed as a Director was appointed as a Director on 06 Nov 2009 & has been associated with this company since 15 years 4 months .
- Director Appointment
Gopalakrishnan Srinivasan was appointed as a Managing Director was appointed as a Managing Director on 06 Nov 2009 & has been associated with this company since 15 years 4 months .
Frequently asked questions
What is the Incorporation or founding date of Inex Medicaments Private Limited?
Inex Medicaments Private Limited was incorporated on 06 Nov 2009.
What is authorized share capital and paid-up capital of Inex Medicaments Private Limited?
The authorized share capital of Inex Medicaments Private Limited is ₹ 0.50 M and paid-up capital is ₹ 0.50 M.
Who are the current board members & directors of Inex Medicaments Private Limited?
Currently 2 directors are associated with Inex Medicaments Private Limited.
- Ajithkumar
- Gopalakrishnan Srinivasan
What is the registered address of Inex Medicaments Private Limited?
As per Ministry of Corporate Affairs (Mca), the registered address of Inex Medicaments Private Limited is No.22 Villa A B Second Floor Rajiv Street Kamaraj Nagar, Keelkatta India, Chennai, Tamil Nadu, 600117.
What is the corporate identification number (CIN) and company number of Inex Medicaments Private Limited?
The corporate identification number (CIN) of Inex Medicaments Private Limited is U51909TN2009PTC073452 and the company number is 073452 as per Ministry of Corporate Affairs (MCA).
What is the official website of Inex Medicaments Private Limited?
The Official website of Inex Medicaments Private Limited is https://www.inexmedicaments.com
What has been the recent revenue trend for Inex Medicaments Private Limited?
According to the financial reports for the fiscal year 2023, the revenue trend for Inex Medicaments Private Limited has risen by 4.75%.
What change has been observed in the net worth of Inex Medicaments Private Limited, and by what percentage?
The financial reports for the fiscal year 2023 indicates that The net worth of Inex Medicaments Private Limited has experienced an upsurge of 15.14%.
What are the total open charges for Inex Medicaments Private Limited?
As per the financial statements for fiscal Year 2023, The total open charges for Inex Medicaments Private Limited amount to ₹ 1.50 Cr.
When was the last Balance Sheet of Inex Medicaments Private Limited filed with the ROC?
The most recent Balance Sheet for Inex Medicaments Private Limited was filed with the ROC on 31 Mar 2024.
People also Viewed
DK
Damodaran KumarDirectorPD
Prem DhananjeyanDirectorVK
Venkat KrishnanDirectorSG
Sundar GovindaswamyDirectorOM
Obula MuralidharanDirectorSJ
Seshadhri JanarthanamDirectorDK
Dilli KarthikeyanDirectorDM
Dineshkumar ManivannanDirector